Development of a Novel DNA Aptamer Ligand Targeting to Primary Cultured Tumor Endothelial Cells by a Cell-Based SELEX Method

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Ara, Mst Naznin ^a   Hyodo, Mamoru ^a   Ohga, Noritaka ^a   Hida, Kyoko ^a   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; CELL SURFACE PROTEIN; DNA; LIGAND;

ANALYTIC METHOD; ANGIOGENESIS; ARTICLE; BINDING AFFINITY; CELL CULTURE; CONFOCAL LASER MICROSCOPY; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CARCINOMA; SOLID TUMOR; SYSTEMIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; DNA PRIMERS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; LIGANDS; MICROSCOPY, CONFOCAL; NEOPLASMS; POLYMERASE CHAIN REACTION; SELEX APTAMER TECHNIQUE; TUMOR CELLS, CULTURED;

EID: 84870748229     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050174     Document Type: Article

References (46)

1. Folkman J, (1971) Tumor angiogenesis, therapeutic implications. N Eng J Med 285: 1182-1186.
2. Folkman J, (2007) Angiogenesis, an organizing principle for drug discovery? Nat Rev Drug Discov 6: 273-286.
3. Ferrara N, Kerbel RS, (2005) Angiogenesis as therapeutic target. Nature 438: 967-974.
4. Akino T, Hida K, Hida Y, Tsuchiya K. Freedman D, (2009) Cytogenic abnormalities of tumor-associated endothelial cells in human malignant tumors. Am J pathol 175: 2657-2667.
5. Hida K, Hida H, Shindoh M, (2008) Understanding tumor endothelial cell abnormalities to develop ideal antiangiogenic therapy. Cancer Sci 99: 459-466.
6. Hida K, Hida Y, Amin DN, Flint AF, Panigrahy D, et al. (2004) Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res 64: 8249-8255.
7. Ellington AD, Szostak JW, (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822.
8. Tuerk C, Gold L, (1990) Systematic evolution of ligands by exponential enrichment, RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510.
9. Shangguan D, Li Y, Tang Z, Cao ZC, Chen HW, et al. (2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA 103: 11838-11843.
10. Tang J, Parekh P, Turner P, Moyer RW, Tan W, (2009) Generating aptamers for recognition of virus-infected cells. Clin Chem 55: 813-822.
11. Sefah K, Meng L, Lopez-Colon D, Jimenez E, Liu C, et al. (2010) DNA aptamers as molecular probes for colorectal cancer study. PLoS One 5: 1-14.
12. Zhao Z, Xu L, Shi X, Tan W, Fang X, et al. (2009) Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells. Analyst 134: 1808-1814.
13. Sefah K, Tan ZW, Shangguan D, Chen H, Lopez-Colon D, et al. (2009) Molecular recognition of acute myeloid leukemia using aptamers. Leukemia 23: 235-244.
14. Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L, (2003) A tenascin-C aptamer identified by tumor cell SELEX. Proc Natl Acad Sci U S A 100: 15416-15421.
15. Ferreira CSM, Cheung MC, Missailidis S, Bisland S, Gariépy J, (2009) Phototoxic aptamers selectively enter and kill epithelial cancer cells. Nucleic Acids Res 37: 866-876.
16. Colas P, Cohen B, Jessen T, Grishina I, McCoy J, et al. (1996) Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature 380: 548-550.
17. Hicke BJ, Stephens AW, Gould T, Chang YF, Lynott CK, et al. (2006) Tumor targeting by an aptamer. J Nucl Med 47: 668-678.
18. Morris KN, Jensen KB, Julin CM, Weil M, Gold L, (1997) High affinity ligands from in vitro selection, Complex targets. Proc Natl Acad Sci U S A 95: 2902-2907.
19. Srisawat C, Engelke DR, (2010) Selection of RNA aptamers that bind HIV-1 LTR DNA duplexes, strand invaders. Nucleic Acids Res 38: 8306-8315.
20. Bunka DHJ, Stockley PG, (2006) Aptamers come of age -at last. Nat Rev Microbiol 4: 588-596.
21. Khati M, (2010) The future of aptamers in medicine. J Clin Pathol 63: 480-487.
22. Keefe AD, Rai S, Ellington A, (2010) Aptamer as therapeutics. Nat Rev Drug Discov 9: 537-550.
23. Tang Z, Shangguan D, Wang K, Shi H, Sefah K, et al. (2007) Selection of aptamers for molecular recognition and characterization of cancer cells. Anal Chem 79: 4900-4907.
24. Xiao Z, Shangguan D, Cao Z, Fang X, Tan W, (2008) Cell specific internalization study of aptamer from whole cell selection. Chem Eur J 14: 1769-1775.
25. Sefah K, Shangguan D, Xiong X, Donoghue MB, Tan W, (2010) Development of DNA aptamer using cell-SELEX. Nat Protoc 5: 1169-1185.
26. Cibiel A, Dupont DM, Duconge F, (2011) Methods to identify aptamers against cell surface biomarkers. Pharmaceuticals 4: 1216-1235.
27. Mallikaratchy P, Tang Z, Kwame S, Meng L, Shangguan D, et al. (2007) Aptamer Directly Evolved From Live Cells Recognizes Membrane Bound Immunoglobin Heavy Mu Chain In Burkits Lymphoma Cells. Mol Cell Proteomics 6: 2230-2238.
28. Shangguan D, Cao Z, Meng L, Mallikaratchy P, Sefah K, et al. (2008) Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J Proteome Res 7: 2133-2139.
29. Berzovski MV, Lechmann M, Musheev MU, Mak TW, Krylov SN, (2008) Aptamer-facilitated biomarker discovery (AptaBiD). J Am Chem Soc 130: 971-983.
30. Shi H, Tang Z, Kim Y, Nie H, Huang YF, et al. (2010) In vivo fluorescence imaging of tumors using molecular aptamers generated by cell-SELEX. Chem Asian J 5: 2209-2213.
31. Sefah K, Phillips JA, Xiong X, Meng L, Simaeys DV, et al. (2009) Nucleic acid aptamers for biosensors, and bio-analytical applications. Analyst 134: 1765-1775.
32. Ray P, White RR, (2010) Aptamers for targeted drug delivery. Pharmaceuticals 3: 1761-1778.
33. Beaucage SL, Iyer RP, (1991) Advance in the synthesis of Oligonucleotides by Phosphoramidite approach. Tetrahedron 48: 2223-2311.
34. Kinouchi T, Kotake T, Mori Y Abe T, (1985) Human renal cell carcinoma, establishment and characterization of a new cell line (OS-RC-2). In Vitro Cell Dev Biol 21: 195-199.
35. Ishii K, Fumoto T, Iwai K, Takeshita S, Ito M, et al. (2009) Co-ordination of PGC-1ß and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med 15: 259-264.
36. Gyllensten UB, Erlich HA, (1988) Generation of single-stranded DNA by polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci U S A 85: 7652-7656.
37. Kurosu T, Ohga N, Hida Y, Maishi N, Akiyama K, et al. (2011) HuR keeps an angiogenic switch on by stabilizing mRNA of VEGF and COX-2 in tumor endothelium. Brit J Cancer 104: 819-829.
38. Arnaoutova I, Kleinman HK, (2010) In vitro angiogenesis, endothelial cell tube formation on gelled basement membrane extract. Nat Protoc 5: 628-635.
39. Arnaoutova I, George J, Kleinman HK, Benton G, (2009) The endothelial cell tube formation assay on basement membrane turns 20, state of the science and the art. Angiogenesis. 12: 267-274.
40. Kandimalla KK, Scott OG, Fulzele S, Davidson MW, Poduslo JF, (2009) Mechanism of Neuronal versus Endothelial cell uptake of Alzheimers disease Amyloid ß Protein. PLoS One 4: e4627.
41. Matsuda K, Ohga N, Hida Y, Muraki C, Tsuchiya K, et al. (2010) Isolated tumor endothelial cells maintain specific character during long-term culture. Biochem Biophys Res Commun 394: 947-954.
42. Ohga N, Ishikawa S, Maishi N, Akiyama K, Hida Y, et al. (2012) Heterogeneity of Tumor Endothelial Cells. Comparison between Tumors Endothelial Cells Isolated from High- and Low-Metastatic Tumors. Am J Pathol 180: 1294-1307.
43. Hida K, Klagsbrun M, (2005) A new perspective on tumor endothelial cells, unexpected chromosome and centrosome abnormalities. Cancer Res 65: 2507-2510.
44. Homann M, Goringer U, (2001) Uptake and intracellular transport of RNA aptamers in African trypanosomes suggest therapeutic Piggy-Back approach. Bioorg Med Chem 9: 2571-2580.
45. Zhang K, Sefah K, Tang L, Zhao Z, Zhu G, et al. (2012) A novel aptamer developed for breast cancer cell internalization. Chem Med Chem 7: 79-84.
46. Reyes-Reyes EM, Teng Y, Bates PJ, (2010) A new paradigm for Aptamer therapeutic AS1411 action, Uptake by macropinocytosis and its stimulation by a Nucleolin dependent mechanism. Cancer Res 70: 8617-8629.